• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
REN Yiwen,LIU Qun,LIU Xiaoqian,XIN Yizhou,DAI Yanpeng.Investigation and analysis of the labeling of "athletes use with caution" of 428 Chinese patent medicine in hospital[J].Journal Of Pharmaceutical Research,2025,44(12):1245-1248[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2384times   Download 761次 QR Code for this article
Scan with your phone!
某院428种中成药“运动员慎用”标注情况调查分析
任依雯1,刘群2,刘晓倩2,辛义周2,戴衍朋3
Font:Larger+|Default|Smaller-
(1.山东中医药大学,山东 济南 250355;2.山东中医药大学附属医院,山东 济南 250011;3.山东省中医药研究院,山东 济南 250014)
摘要:
目的 对中成药说明书或外包装中“运动员慎用”标注情况进行分析,为运动员安全、合理使用中成药提供参考,为含兴奋剂中成药管理提供建议。方法 收集整理某院在用所有中成药说明书及外包装,依据《2024兴奋剂目录》筛选出含兴奋剂成分中成药,并运用对比分析法比较在“运动员慎用”方面标注的差异。结果 共收集到428种中成药说明书及其外包装,其中含兴奋剂成分中成药86种,仅44种说明书或外包装中标注“运动员慎用”,剩余42种未标注,未标注品种所含兴奋剂成分多为去甲乌药碱;未涉及标注但不含有兴奋剂成分情况。结论 应进一步完善中成药“运动员慎用”标注信息,避免运动员医源性误服。同时,建议药品监管部门联合体育总局等部门,加强对含兴奋剂成分中成药管理,进一步规范含兴奋剂中成药临床使用。
关键词:  中成药  说明书  兴奋剂  运动员慎用
DOI:10.13506/j.cnki.jpr.2025.12.015
基金项目:山东省药物政策研究重点课题(No.YZY202407);齐鲁卫生与健康领军人才项目(No.2019);山东省中医药科技重点项目(No.Z-2023052);山东省药品临床综合评价项目(No.2022YZ003);山东中医药学会临床药学科研专项基金项目(No.SDACM202204);2023年度山东药品化妆品监测哨点课题(No.2023SDADRKY47)
Publication Date:December 25, 2025
Investigation and analysis of the labeling of "athletes use with caution" of 428 Chinese patent medicine in hospital
REN Yiwen1,LIU Qun2,LIU Xiaoqian2,XIN Yizhou2,DAI Yanpeng3
(1.Shandong University of Traditional Chinese Medicine,Jinan 250355,China; 2.Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China;3.Shandong Academy of Chinese Medicine,Jinan 250014,China)
Abstract:
Objective To analyze the specific situation of "Athletes use with caution" in the instructions or outer packaging of Chinese patent medicine(CPM), to provide reference for the safe and rational use of CPM by athletes, and to provide suggestions for the management of CPM containing stimulants.Methods All the instructions or outer packaging of CPM in use in a hospital were collected and sorted out, the CPM containing doping ingredients were screened according to the "2024 Doping Catalogue", and the differences compared by Comparative analysis method in the labeling of "Athletes use with caution".Results A total of 428 kinds of traditional Chinese patent medicines and simple preparations were collected, including 86 kinds of traditional Chinese patent medicines and simple preparations containing stimulant ingredients. Only 44 kinds of instructions or packages were marked with "athletes use with caution", and the remaining 42 kinds were not marked. Most of the stimulant ingredients contained in the unmarked varieties were higenamine. No labelling but no stimulant content is involved.Conclusion The labeling information or outer packaging of "Athletes use with caution" should be further improved to avoid iatrogenic misuse. At the same time, it is suggested that the drug regulatory department, together with the General Administration of Sports and other departments, strengthen the management of CPM containing stimulants and further regulate the clinical use of CPM containing stimulants.
Key words:  Chinese patent medicine  Instructions  Stimulant  Athletes use with caution
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.